Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Azithromycin in Children with Acute Otitis Media
NCT00315003Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Jul 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of telithromycin in acute otitis media (AOM), sponsored by Sanofi. Started Jan 2006; status: terminated.
02
Drugs
telithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00315003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315003.